News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
144,599 Results
Type
Article (14294)
Company Profile (12)
Press Release (130293)
Section
Business (39697)
Career Advice (308)
Deals (5373)
Drug Delivery (13)
Drug Development (18478)
Employer Resources (33)
FDA (2834)
Job Trends (3167)
News (65825)
Policy (5337)
Tag
Academia (1697)
Alliances (12519)
Alzheimer's disease (437)
Approvals (2823)
Artificial intelligence (34)
Bankruptcy (31)
Best Places to Work (2685)
Breast cancer (33)
Cancer (332)
Career advice (266)
CAR-T (18)
Cell therapy (59)
Clinical research (13954)
Collaboration (107)
COVID-19 (1005)
C-suite (23)
Cystic fibrosis (18)
Data (243)
Diagnostics (1590)
Drug discovery (18)
Earnings (8809)
Employer resources (28)
Events (18487)
Executive appointments (68)
FDA (2949)
Funding (132)
Gene therapy (49)
GLP-1 (95)
Government (1134)
Healthcare (4860)
Infectious disease (1029)
Inflammatory bowel disease (27)
Interviews (36)
IPO (2712)
Job creations (556)
Job search strategy (249)
Layoffs (41)
Legal (940)
Liver cancer (18)
Lung cancer (56)
Manufacturing (32)
Medical device (2410)
Medtech (2410)
Mergers & acquisitions (2723)
Metabolic disorders (35)
Neuroscience (495)
NextGen Class of 2024 (1642)
Non-profit (1881)
Northern California (277)
Opinion (47)
People (15010)
Phase I (4730)
Phase II (6425)
Phase III (4209)
Pipeline (91)
Policy (37)
Postmarket research (549)
Preclinical (2172)
Press Release (18)
Radiopharmaceuticals (45)
Rare diseases (43)
Real estate (1207)
Regulatory (3528)
Research institute (1860)
Resumes & cover letters (36)
Series A (19)
Southern California (236)
Startups (1067)
United States (2704)
Vaccines (173)
Date
Last 7 days (162)
Last 30 days (655)
Last 365 days (7439)
2024 (6742)
2023 (8720)
2022 (11561)
2021 (12943)
2020 (12301)
2019 (11095)
2018 (8181)
2017 (7397)
2016 (7464)
2015 (8756)
2014 (6506)
2013 (5351)
2012 (5460)
2011 (5675)
2010 (4824)
Location
Africa (188)
Alabama (20)
Arizona (38)
Asia (9098)
Australia (2016)
California (600)
Canada (218)
China (44)
Colorado (34)
Connecticut (31)
Europe (18821)
Florida (126)
Illinois (92)
Indiana (33)
Japan (19)
Kansas (21)
Maryland (103)
Massachusetts (442)
Minnesota (49)
New Jersey (262)
New York (205)
North Carolina (124)
Northern California (277)
Ohio (36)
Pennsylvania (140)
South America (248)
Southern California (236)
Texas (134)
Washington D.C. (21)
Washington State (82)
144,599 Results for "kennedy krieger institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
New MOMENTUM Magnetic Particle Imaging Scanner installed at Kennedy Krieger Institute
The first East Coast installation of the MOMENTUM Magnetic Particle Imaging (MPI) scanner has been completed at Kennedy Krieger Institute in Baltimore, MD.
January 12, 2022
·
1 min read
Drug Development
ORYZON Starts Preclinical Collaboration on Kabuki Syndrome with Kennedy Krieger Institute and Johns Hopkins University
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the start of a preclinical collaboration on Kabuki Syndrome with researchers from Kennedy Krieger Institute and Johns Hopkins University.
May 3, 2022
·
5 min read
Business
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Carisma Therapeutics Inc. today announced the appointment of Eugene P. Kennedy, M.D., F.A.C.S. as the Company’s Chief Medical Officer.
May 2, 2024
·
3 min read
Business
Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of a new independent director, Patrick Kennedy, to its Board of Directors.
February 27, 2024
·
4 min read
Biotech Beach
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study
Daré Bioscience, Inc. today announced that it received a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a division of the National Institutes of Health (NIH).
December 13, 2023
·
10 min read
Press Releases
CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
September 12, 2024
·
4 min read
Press Releases
Hinge Bio, Inc. Chief Scientific Officer, Daniel Capon, Ph.D., to Present its GEM-DIMER™ Platform Technology at the University of Oxford, Kennedy Institute of Rheumatology’s Annual Translational Research Conference
August 14, 2024
·
3 min read
Drug Development
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease)
Avenue Therapeutics, Inc. today announced the completion of the last patient’s final visit in the Company’s Phase 1b/2a clinical trial of AJ201 for the treatment of spinal and bulbar muscular atrophy (“SBMA”), also known as Kennedy’s Disease.
May 16, 2024
·
10 min read
Government
Trump Picks RFK Jr. to Lead HHS
Trump’s HHS pick, Robert F. Kennedy Jr., is an anti-vaccine campaigner who has previously said that he plans to gut the FDA on allegations of corruption and reduce the NIH’s headcount.
November 15, 2024
·
3 min read
·
Tristan Manalac
Podcast
RFK Jr.’s HHS Nomination, Biogen’s Lupus Win and Leqembi Struggles, Neurogene’s Rough Month, More
Trump fingers Robert F. Kennedy Jr. to lead the HHS, lupus and ATTR-CM dominate headlines this week, bluebird bio has a cash gap to leap and RegenxBio eyes Sarepta in Duchenne muscular dystrophy.
November 20, 2024
·
1 min read
·
Heather McKenzie
1 of 14,460
Next